Doctor profile · Federal record

Dr. Mark Gallardo, MD

Dermatology Physician (CMS: Dermatology) · Hattiesburg, MS

  • NPI 1336159607
  • Accepts Medicare
  • 32 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
104 Asbury Cir
Hattiesburg, MS 394021302
(601) 268-5252
fax (601) 268-5190
Mailing address
415 S 28Th Ave
Hattiesburg, MS 394017246

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
July 14, 2020
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Mississippi #17102
Medicaid (2)
MS #00123829 · LA #1768162

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1336159607. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
26,015
Distinct HCPCS
10
Medicare allowed
$662,398
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 12,200 41 $2
17003 Destruction of precancer skin growth, 2-14 growths 6,651 844 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 2,528 1,603 $83
17000 Destruction of precancer skin growth, 1 growth 1,372 978 $46
11102 Biopsy of related skin growth, first growth 882 701 $83
17110 Destruction of skin growth, 1-14 growths 633 540 $99
11103 Biopsy of related skin growth, each additional growth 260 176 $45
99203 New patient office or other outpatient visit, 30-44 minutes 258 258 $103
99212 Established patient office or other outpatient visit, 10-19 minutes 145 112 $51
11642 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm 109 92 $156

In context: peer comparison

Among 4 peers in Hattiesburg Dermatology Physician, average services per provider: 387. This provider delivers 67× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,322
Transactions
67
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 27 $319.69
Ortho Dermatologics, A Division of Bausch Health US, LLC 7 $206.36
E.R. Squibb & Sons, L.L.C. 7 $131.80
Amgen INC. 6 $117.22
Genzyme Corporation 6 $109.99
Arcutis Biotherapeutics, INC. 3 $99.30
Janssen Biotech, INC. 1 $94.99
Incyte Corporation 3 $52.48
Hill Dermaceuticals, INC. 1 $39.60
Leo Pharma INC. 1 $21.62
Almirall LLC 1 $18.75
Abbvie INC. 1 $17.70
Dermavant Sciences, INC. 1 $17.54
Strata Skin Sciences, INC. 1 $16.80
Sun Pharmaceutical Industries INC. 1 $16.56

By nature of payment

Food and Beverage
$1,227
Education
$95

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,543
Patients
996
Total drug cost
$362,759
Drug Type Claims Patients Total cost
Cephalexin Generic 304 238 $709
Triamcinolone Acetonide Generic 235 141 $4,191
Ketoconazole Generic 147 83 $3,048
Mupirocin Generic 136 98 $1,435
Mometasone Furoate Generic 118 80 $3,813
Doxycycline Hyclate Generic 108 56 $1,773
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 101 91 $201
Metronidazole Generic 70 35 $6,582
Ciclopirox Generic 67 37 $3,163
Terbinafine Hcl Generic 62 36 $564

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Gallardo's medical specialty?
Dr. Mark Gallardo practices Dermatology Physician in Hattiesburg, MS.
Where does Dr. Mark Gallardo practice?
Dr. Mark Gallardo practices at 104 Asbury Cir, Hattiesburg, MS 394021302. Office phone: 6012685252.
What is Dr. Mark Gallardo's NPI?
Dr. Mark Gallardo's National Provider Identifier (NPI) is 1336159607, issued by NPPES.
Does Dr. Mark Gallardo accept Medicare assignment?
Yes. Dr. Mark Gallardo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Gallardo commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.